Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells

The nitric oxide (NO) prodrug JS-K is shown to have anticancer activity. To profile the molecular events associated with anticancer effects of JS-K, HL-60 leukemia cells were treated with JS-K and subjected to microarray and real-time RT-PCR analysis. JS-K induced concentration- and time-dependent g...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Liu, Jie, Malavya, Swati, Wang, Xueqian, Saavedra, Joseph E., Keefer, Larry K., Tokar, Erik, Qu, Wei, Waalkes, Michael P., Shami, Paul J.
Формат: Artigo
Язык:Inglês
Опубликовано: 2009
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496159/
https://ncbi.nlm.nih.gov/pubmed/19348908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygeno.2009.03.005
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы